首页> 外国专利> FASTING MIMICKING DIET (FMD), AND GLUCOSE-LOWERING DRUGS, PROTECTING NORMAL CELLS AND CREATING CONDITIONS OF CANCER SENSITIZATION IN RESPONSE TO STANDARD CONDITIONS AND CONDITIONS WITH HIGH CONTENT OF GLUCOSE INDUCED BY RAPAMYCIN AND DEXAMETHASONE

FASTING MIMICKING DIET (FMD), AND GLUCOSE-LOWERING DRUGS, PROTECTING NORMAL CELLS AND CREATING CONDITIONS OF CANCER SENSITIZATION IN RESPONSE TO STANDARD CONDITIONS AND CONDITIONS WITH HIGH CONTENT OF GLUCOSE INDUCED BY RAPAMYCIN AND DEXAMETHASONE

机译:响应雷帕霉素和地塞米松诱导的高含量葡萄糖的标准条件和饮食,快速食用模仿饮食(FMD)和降低葡萄糖的药物,保护正常细胞并提高癌症致敏性的条件

摘要

A method for treating a hyperglycemia and hyperglycemia-dependent side effects in a subject undergoing chemotherapy includes a step of identifying a subject undergoing chemotherapy and being administered a hyperglycemia-inducing agent. Short-term starvation or a fasting mimicking diet is administered for a first time period to the subject to prevent hyperglycemia and sensitization to chemotherapy associated with increased glucose levels. The STS-mimicking drug Metformin is administrated between STS/FMD cycles to maintain STS-/FMD-like conditions during the re-feeding period.
机译:在正在接受化学疗法的受试者中治疗高血糖和高血糖依赖的副作用的方法包括确定正在接受化学疗法的受试者并被给予高血糖诱导剂的步骤。在第一时间段内,向受试者施用短期饥饿或禁食模拟饮食,以防止高血糖和对与葡萄糖水平升高相关的化学疗法的敏感性。模仿STS的药物二甲双胍在STS / FMD周期之间给药,以在重新喂食期间维持类似STS / FMD的状况。

著录项

  • 公开/公告号RU2017136423A3

    专利类型

  • 公开/公告日2019-09-04

    原文格式PDF

  • 申请/专利权人

    申请/专利号RU20170136423

  • 发明设计人

    申请日0000-00-00

  • 分类号A61K31/436;A61K31/573;A61P3/10;

  • 国家 RU

  • 入库时间 2022-08-21 11:46:59

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号